Latest filing published 03 Aug 2021 for Apellis Pharmaceuticals, Inc., €54k.
Filing timeline
BuySaleInsider track record
Nicole D. Perry: trading record in brief
This profile gathers the share dealings of Nicole D. Perry in Apellis Pharmaceuticals, Inc., where the filings describe the role as chief executive. The record holds 23 filings, for trades running from 10 February 2020 to 2 August 2021.
Sales make up the whole of the open-market record (10 sales, €1.3M). The rest of the record consists of 3 share grants and 10 option exercises. So far in 2021, the count stands at no purchases and 9 sales.
The record was last updated on 3 August 2021 with an open-market sale (€54k) in Apellis Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Nicole D. Perry
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$63.993.9% of flowCommon StockSEC:0001127602-21-022938:1
- 1,000 shares@ US$3.7617.3% of flowCommon StockSEC:0001127602-21-022938:0
- 1,000 shares@ US$64.003.9% of flowCommon StockSEC:0001127602-21-021194:1
- 1,000 shares@ US$3.7617.4% of flowCommon StockSEC:0001127602-21-021194:0
- 1,000 shares@ US$61.563.6% of flowCommon StockSEC:0001127602-21-019902:1
- 1,000 shares@ US$3.2014.4% of flowCommon StockSEC:0001127602-21-019902:0
- 1,000 shares@ US$56.403.3% of flowCommon StockSEC:0001127602-21-018704:1
- 1,000 shares@ US$3.7616.8% of flowCommon StockSEC:0001127602-21-018704:0
- 1,000 shares@ US$50.733.0% of flowCommon StockSEC:0001127602-21-015186:1
- 1,000 shares@ US$3.7617.1% of flowCommon StockSEC:0001127602-21-015186:0
- 1,000 shares@ US$50.003.0% of flowCommon StockSEC:0001127602-21-014986:1
- 1,000 shares@ US$3.7617.0% of flowCommon StockSEC:0001127602-21-014986:0
- 2,000 shares@ US$3.760.4% of flowCommon StockSEC:0001127602-21-009099:0
- 2,000 shares@ US$50.006.0% of flowCommon StockSEC:0001127602-21-009099:1
- 153 shares@ US$47.720.4% of flowCommon StockSEC:0001127602-21-005222:0
- 2,000 shares@ US$3.760.4% of flowCommon StockSEC:0001127602-21-004949:0
- 2,000 shares@ US$50.006.0% of flowCommon StockSEC:0001127602-21-004949:1
- 2,500 shares0Common StockSEC:0001127602-21-003231:0
- 2,000 shares@ US$3.760.4% of flowCommon StockSEC:0001127602-21-000517:0
- 2,000 shares@ US$57.246.7% of flowCommon StockSEC:0001127602-21-000517:1
- 18,000 shares@ US$3.766.8% of flowCommon StockSEC:0001127602-20-030926:0
- 18,000 shares@ US$50.0090.9% of flowCommon StockSEC:0001127602-20-030926:1
- 2,500 shares0Common StockSEC:0000899243-20-004275:0
23 of 23 declarations
